Cargando…
Relationship Between (18)F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level
To evaluate clinical values of clinicopathologic and (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT)-related parameters for prediction of v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation in colorectal cancer (CRC) and to investigate...
Autores principales: | Lee, Jae-Hoon, Kang, Jeonghyun, Baik, Seung Hyuk, Lee, Kang Young, Lim, Beom Jin, Jeon, Tae Joo, Ryu, Young Hoon, Sohn, Seung-Kook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706250/ https://www.ncbi.nlm.nih.gov/pubmed/26735530 http://dx.doi.org/10.1097/MD.0000000000002236 |
Ejemplares similares
-
Kirsten Ras* oncogene: Significance of its discovery in human cancer research
por: Tsuchida, Nobuo, et al.
Publicado: (2016) -
The efficacy of cap-assisted colonoscopy performed by a single endoscopist in patients after colorectal resection
por: Kim, Im-kyung, et al.
Publicado: (2016) -
Circumferential Resection Margin Involvement in Stage III Rectal Cancer Patients Treated with Curative Resection Followed by Chemoradiotherapy: A Surrogate Marker for Local Recurrence?
por: Kang, Jeonghyun, et al.
Publicado: (2013) -
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
por: Andreyev, H J N, et al.
Publicado: (2001) -
MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation
por: Wang, Yuan, et al.
Publicado: (2015)